Efficacy of BREATHOX
SARS-CoV-2
hypertonic saline
mild COVID-19
treatment
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
20 Sep 2023
20 Sep 2023
Historique:
received:
03
08
2023
revised:
06
09
2023
accepted:
11
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
(1) Background: A high concentration of sodium chloride on in vitro cell culture leads to reduced SARS-CoV-2 replication. Therefore, our aim was to evaluate the effects of inhaling hypertonic NaCl particles (BREATHOX
Identifiants
pubmed: 37763015
pii: jcm12186075
doi: 10.3390/jcm12186075
pmc: PMC10531785
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Liita Care
ID : na
Références
Ann Palliat Med. 2021 Jan;10(1):672-680
pubmed: 33545796
Eur Respir J. 2000 Jun;15(6):1116-9
pubmed: 10885433
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Pharm Anal. 2020 Apr;10(2):102-108
pubmed: 32282863
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1810-5
pubmed: 11734428
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1285-7
pubmed: 6794821
ACS Pharmacol Transl Sci. 2021 Sep 03;4(5):1514-1527
pubmed: 34651104
J Phys Chem Lett. 2020 Dec 17;11(24):10446-10453
pubmed: 33269932
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):647-652
pubmed: 32238232
Cochrane Database Syst Rev. 2000;(2):CD001506
pubmed: 10796798
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004